Trial intelligence / Profile preview

Lyophilized human rabies vaccine (Vero cell) 4-dose vs 5-dose regimen Phase III trial

CTR20182016Phase 3Completed

Sponsor
Shandong Yidu Biotechnology
Start
Nov 2018
Modality
Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of Rabies vaccine in rabies, sponsored by Shandong Yidu Biotechnology. Started Nov 2018; status: completed.

02

Drugs

Rabies vaccine
03

Conditions

rabies

Beyond the preview

Go deeper on CTR20182016.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20182016.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call